- Investing Ideas
- /
- U.S. Pharmaceuticals & Biotech Net Cash Stocks With A Growth Track Record
U.S. Pharmaceuticals & Biotech Net Cash Stocks With A Growth Track Record
Results
2
0 new
These companies have grown profits at a double digit rate for 5 years or more. And they have net cash.
2 companies
Niagen Bioscience
Market Cap: US$462.1m
Operates as a bioscience company engages in developing healthy aging products.
NAGE
US$5.93
7D
-1.4%
1Y
54.0%
SIGA Technologies
Market Cap: US$425.4m
A commercial-stage pharmaceutical company, focuses on the health security related markets in the United States.
SIGA
US$5.96
7D
10.5%
1Y
-32.4%